Northern Trust
MIRA icon

Northern Trust’s MIRA Pharmaceuticals MIRA Stock Holding History

Northern Trust’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64.1K Buy
67,735
+37
+0.1% +$37 ﹤0.01% 4224
2026
Q1 		$72.4K Hold
67,698
– – ﹤0.01% 4177
2025
Q4 		$102K Buy
67,698
+23,966
+55% +$35.2K ﹤0.01% 4135
2025
Q3 		$59.5K Buy
43,732
+30,137
+222% +$43.7K ﹤0.01% 4252
2025
Q2 		$16.4K Hold
13,595
– – ﹤0.01% 4352
2025
Q1 		$13.3K Sell
13,595
-16,767
-55% -$19.1K ﹤0.01% 4373
2024
Q4 		$34.6K Buy
30,362
+10,238
+51% +$13.4K ﹤0.01% 4315
2024
Q3 		$26.2K Sell
20,124
-330
-2% -$526 ﹤0.01% 4310
2024
Q2 		$13K Hold
20,454
– – ﹤0.01% 4363
2024
Q1 		$22.5K Hold
20,454
– – ﹤0.01% 4321
2023
Q4 		$21.5K Buy
+20,454
New +$52K ﹤0.01% 4355

Other funds holding MIRA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CSI
Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return
FAB
First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Northern Trust's MIRA Position: Q2 2026 in Review

Northern Trust increased its MIRA Pharmaceuticals (MIRA) stake by 0.05% in Q2 2026, buying an estimated $37 and bringing the position to 67,735 shares worth $64.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4224.

Northern Trust first reported a position in MIRA in Q4 2023 and has held it in 11 quarters since. The position peaked at $102K in Q4 2025. 26 funds tracked by Wall St. Rank hold MIRA as of Q2 2026.

  • Northern Trust held 67,735 shares of MIRA Pharmaceuticals worth $64.1K as of Q2 2026.
  • Northern Trust bought 37 MIRA Pharmaceuticals shares in Q2 2026, an estimated $37.
  • MIRA Pharmaceuticals made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4224 holding.
  • Northern Trust first reported a position in MIRA Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • Northern Trust's MIRA Pharmaceuticals position peaked at $102K in Q4 2025.
  • 26 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.